Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension-Reference-Cited by-同舟云学术

Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Published:2021-02-24 Issue:4 Volume:38 Page:1757-1775
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Araie Makoto,Sugiyama Kazuhisa,Aso Kenji,Kanemoto Koji,Kothapalli Kalyani,Kopczynski Casey,Senchyna Michelle,Hollander David A.

Funder

Aerie Pharmaceuticals Limited

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-021-01634-9.pdf

Reference43 articles.

1. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–11.

2. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.

3. Japan Glaucoma Society Glaucoma Practice Guidelines Development Committee. Glaucoma medical care guideline 4th edition. Nichigankaishi. 2018;122:5–53.

4. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi study. Ophthalmology. 2004;111:1641–8.

5. Yamamoto T, Iwase A, Araie M, et al. Prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112:1661–9.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages and disadvantages of using Rho kinase inhibitors to reduce intraocular pressure;Expert Review of Ophthalmology;2024-02-12

2. Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension;Indian Journal of Ophthalmology;2023-12-26

3. Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET);Advances in Therapy;2023-08-21

4. Pediatric Glaucoma—From Screening, Early Detection to Management;Children;2023-01-18

5. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension;Cochrane Database of Systematic Reviews;2022-06-10